VISN.H — Binovi Technologies Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Binovi Technologies, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.
2018 February 28th | 2019 February 28th | C2020 February 29th | R2021 February 28th | 2022 February 28th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.099 | 0.667 | 0.696 | 0.728 | 0.186 |
Cost of Revenue | |||||
Gross Profit | 0.085 | 0.376 | 0.594 | 0.523 | 0.132 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.8 | 5.25 | 8.34 | 9.58 | 16.6 |
Operating Profit | -2.7 | -4.58 | -7.65 | -8.85 | -16.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.71 | -4.77 | -7.69 | -9.14 | -16.4 |
Net Income After Taxes | -2.71 | -4.77 | -7.69 | -9.14 | -16.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.71 | -4.77 | -7.69 | -9.14 | -16.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.71 | -4.77 | -7.69 | -9.14 | -16.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -4.07 | -4.65 | -3.65 | -1.03 | -0.294 |